Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Medtronic
Federal Trade Commission
Mallinckrodt
Deloitte
US Army
Fuji
Farmers Insurance
Cerilliant

Generated: January 23, 2018

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; propranolol hydrochloride and what is the scope of hydrochlorothiazide; propranolol hydrochloride patent protection?

Hydrochlorothiazide; propranolol hydrochloride
is the generic ingredient in seven branded drugs marketed by Wyeth Ayerst, Wyeth Pharms Inc, Duramed Pharms Barr, Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Sandoz, Warner Chilcott, and Watson Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; propranolol hydrochloride. One supplier is listed for this compound.
Summary for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
Pharmacology for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070301-001 Apr 18, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc INDERIDE-40/25 hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 018031-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst INDERIDE LA 160/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-003 Jul 3, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071126-001 Mar 2, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071127-001 Mar 2, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071772-001 Jan 26, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071552-001 Dec 1, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071060-001 Aug 26, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070947-001 Apr 1, 1987 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc INDERIDE-80/25 hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 018031-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst INDERIDE LA 120/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-002 Jul 3, 1985 ➤ Subscribe ➤ Subscribe
Wyeth Ayerst INDERIDE LA 160/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-003 Jul 3, 1985 ➤ Subscribe ➤ Subscribe
Wyeth Ayerst INDERIDE LA 80/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-001 Jul 3, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Merck
Cantor Fitzgerald
Moodys
McKesson
AstraZeneca
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot